You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTCT Sale Disclosure
Smith Mary L. · SEC Form 4 · Filed Jul 13, 2026
Sale
Calculated transaction value
$900K
Smith Mary L. Director
PTCT
PTC Therapeutics
PTCT
Transaction date
Jul 9, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 4 days later
PTCT daily price context
Close on/before transaction
$89.55
Jul 9, 2026
First close after public filing
$78.06
Jul 14, 2026
30-day return after filing
-6.94%
Through Aug 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $90
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001866044-26-000005
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$2.11M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Exercise | Jul 9, 2026 | $429.5K |
| Ptc Therapeutics, Inc. PTCT Current | Sale | Jul 9, 2026 | $900K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jul 9, 2026 | $250.57K |
| Ptc Therapeutics, Inc. PTCT | Sale | Jul 9, 2026 | $525.06K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jul 9, 2026 | $0 |
| Ptc Therapeutics, Inc. PTCT | Exercise | Jul 9, 2026 | $0 |